| 600062 |
2021/12/30 |
2021 Annual Report |
2 |
Other business |
77880085.16 |
0.0085 |
0.401505538 |
Renminbi |
| 600062 |
2021/12/30 |
2021 Annual Report |
3 |
Central China and East China |
4243346292 |
0.4657 |
0.633039259 |
Renminbi |
| 600062 |
2021/12/30 |
2021 Annual Report |
3 |
North China |
1933752503 |
0.2122 |
0.496964849 |
Renminbi |
| 600062 |
2021/12/30 |
2021 Annual Report |
3 |
South China and Southwest China |
1336424027 |
0.1467 |
0.613290483 |
Renminbi |
| 600062 |
2021/12/30 |
2021 Annual Report |
3 |
Other regions |
612352062.3 |
0.0672 |
0.181447409 |
Renminbi |
| 600062 |
2021/12/30 |
2021 Annual Report |
3 |
Northwestern Territory |
536168251.7 |
0.0588 |
0.460085573 |
Renminbi |
| 600062 |
2021/12/30 |
2021 Annual Report |
3 |
Northeast Region |
371593709.1 |
0.0408 |
0.607259941 |
Renminbi |
| 600062 |
2021/12/30 |
2021 Annual Report |
3 |
Other business |
77880085.16 |
0.0086 |
0.401505538 |
Renminbi |
| 600062 |
2021/9/29 |
2021 Third Quarterly Report |
1 |
Non-infusion |
4790194383 |
0.6967 |
0.597787709 |
Renminbi |
| 600062 |
2021/9/29 |
2021 Third Quarterly Report |
1 |
Infusion |
2029380092 |
0.2952 |
0.536030047 |
Renminbi |
| 600062 |
2021/9/29 |
2021 Third Quarterly Report |
1 |
Other business |
55728408.98 |
0.0081 |
0.384180247 |
Renminbi |
| 600062 |
2021/9/29 |
2021 Third Quarterly Report |
2 |
Chronic disease platform |
2279885464 |
0.3316 |
0.794543258 |
Renminbi |
| 600062 |
2021/9/29 |
2021 Third Quarterly Report |
2 |
Infusion platform |
2029380092 |
0.2952 |
0.536030047 |
Renminbi |
| 600062 |
2021/9/29 |
2021 Third Quarterly Report |
2 |
Others |
1536789139 |
0.2235 |
0.210035488 |
Renminbi |
| 600062 |
2021/9/29 |
2021 Third Quarterly Report |
2 |
Specialist platform |
973519779.7 |
0.1416 |
0.74910799 |
Renminbi |
| 600062 |
2021/9/29 |
2021 Third Quarterly Report |
2 |
Other business |
55728408.98 |
0.0081 |
0.384180247 |
Renminbi |
| 600062 |
2021/6/29 |
2021 Interim Report |
1 |
Non-infusion |
3255435850 |
0.7031 |
0.60005585 |
Renminbi |
| 600062 |
2021/6/29 |
2021 Interim Report |
1 |
Infusion |
1340953648 |
0.2896 |
0.538166566 |
Renminbi |
| 600062 |
2021/6/29 |
2021 Interim Report |
1 |
Other business |
33599464.86 |
0.0073 |
0.495573838 |
Renminbi |
| 600062 |
2021/6/29 |
2021 Interim Report |
2 |
Chronic disease platform |
1550278374 |
0.3348 |
0.794602988 |
Renminbi |
| 600062 |
2021/6/29 |
2021 Interim Report |
2 |
Infusion platform |
1340953648 |
0.2896 |
0.538166566 |
Renminbi |
| 600062 |
2021/6/29 |
2021 Interim Report |
2 |
Others |
1052001142 |
0.2272 |
0.216813105 |
Renminbi |
| 600062 |
2021/6/29 |
2021 Interim Report |
2 |
Specialist platform |
653156334.7 |
0.1411 |
0.755561628 |
Renminbi |
| 600062 |
2021/6/29 |
2021 Interim Report |
2 |
Other business |
33599464.86 |
0.0073 |
0.495573838 |
Renminbi |
| 600062 |
2021/3/30 |
2021 first quarter report |
1 |
Non-infusion |
1732678292 |
0.7272 |
0.627821946 |
Renminbi |
| 600062 |
2021/3/30 |
2021 first quarter report |
1 |
Infusion |
650053918.8 |
0.2728 |
0.506257418 |
Renminbi |
| 600062 |
2021/3/30 |
2021 first quarter report |
2 |
Chronic disease platform |
855887811.4 |
0.3592 |
0.804724624 |
Renminbi |
| 600062 |
2021/3/30 |
2021 first quarter report |
2 |
Infusion platform |
650053918.8 |
0.2728 |
0.506257418 |
Renminbi |
| 600062 |
2021/3/30 |
2021 first quarter report |
2 |
Other |
537776160.3 |
0.2257 |
0.25366611 |
Renminbi |
| 600062 |
2021/3/30 |
2021 first quarter report |
2 |
Specialist platform |
339014319.9 |
0.1423 |
0.77472796 |
Renminbi |
| 600062 |
2020/12/30 |
2020 Annual Report |
1 |
Non-infusion products |
5909454880 |
0.6949 |
0.695430303 |
Renminbi |
| 600062 |
2020/12/30 |
2020 Annual Report |
1 |
Infusion products |
2481789810 |
0.2918 |
0.493733898 |
Renminbi |
| 600062 |
2020/12/30 |
2020 Annual Report |
1 |
Other business |
112693540.2 |
0.0133 |
0.211093678 |
Renminbi |
| 600062 |
2020/12/30 |
2020 Annual Report |
2 |
Chronic disease business platform |
3442094705 |
0.4048 |
0.825177019 |
Renminbi |
| 600062 |
2020/12/30 |
2020 Annual Report |
2 |
Infusion business platform |
2481789810 |
0.2918 |
0.493733898 |
Renminbi |
| 600062 |
2020/12/30 |
2020 Annual Report |
2 |
Specialty Business Platform |
1249751438 |
0.147 |
0.746334859 |
Renminbi |
| 600062 |
2020/12/30 |
2020 Annual Report |
2 |
Other |
1217608736 |
0.1432 |
0.276397069 |
Renminbi |
| 600062 |
2020/12/30 |
2020 Annual Report |
2 |
Other business |
112693540.2 |
0.0132 |
0.211093678 |
Renminbi |
| 600062 |
2020/12/30 |
2020 Annual Report |
3 |
Central China and East China |
4721285955 |
0.5552 |
0.711723815 |
Renminbi |
| 600062 |
2020/12/30 |
2020 Annual Report |
3 |
North China |
1612633383 |
0.1896 |
0.409359941 |
Renminbi |
